Discuss PSEN2 test results in a planned counseling visit with a trusted support person present and clear next steps for care and family communication. PSEN2 is a deterministic autosomal-dominant Alzheimer gene that carries a very strong probability of Alzheimer's before age 65 when inherited. Younger adults with memory problems need plain language plus context about variability. PSEN2 varies widely in onset and penetrance, so the conversation should separate what the result changes now from what needs monitoring.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What a positive PSEN2 result means
- Who is usually offered this test
- How should the results conversation happen
- What families need to decide next
What a positive PSEN2 result means
According to the U.S. Alzheimer's Genetics Fact Sheet, a child of a carrier has a 50% chance to inherit the variant. If inherited, the fact sheet reports a very strong probability of developing Alzheimer's before age 65.
The NCBI GeneReviews overview reports PSEN2 causes about 5% of early-onset familial Alzheimer cases. It gives typical symptom onset from age 40 to 75, with reduced penetrance including some carriers still asymptomatic after age 80. An Acta Neuropathologica review describes PSEN2 as rarer and more variable than PSEN1. It reports fewer than 15 pathogenic PSEN2 mutations and incomplete penetrance, versus more than 180 PSEN1 mutations with essentially complete penetrance by age 60-65.
Who is usually offered this test
Clinicians reserve APP/PSEN1/PSEN2 testing for people with early-age symptoms plus a strong family history suggesting dominant inheritance. The U.S. Alzheimer's.gov Genetics Fact Sheet does not recommend it for routine dementia diagnosis or prediction.
In practice, that means early memory problems alone do not prompt PSEN2 testing. Ask about parents, siblings, aunts, uncles, and age at onset across generations. A pattern of early Alzheimer's in successive generations raises the question for genetics referral.
How should the results conversation happen
The 2011 American College of Medical Genetics and National Society of Genetic Counselors guideline says Alzheimer genetic testing should occur only with expert pre-test and post-test counseling. The joint counseling guideline recommends a Huntington-disease-like disclosure protocol with a support person for unimpaired at-risk adults. Use a short, planned structure the patient can follow:.
- State the result first in one plain sentence, then pause.
- Explain inheritance, variability, and what remains uncertain for this person.
- Name next medical steps, brain-health monitoring, and whom to contact with questions.
- Agree on what to tell relatives, when, and who will help.
What families need to decide next
A positive result affects relatives and planning because first-degree relatives face 50% carrier risk. The NCRAD genetic testing resource links this risk information to reproductive decisions, surveillance, and eligibility for dominantly inherited Alzheimer research such as DIAN for APP/PSEN1/PSEN2 families. The same 2011 guideline sets a limit for families: do not perform predictive Alzheimer testing in children. It also advises against prenatal testing when the pregnancy would continue with a mutation.
U.S. law limits but does not remove discrimination risk, according to the Barcelona Summit ethics review. GINA bars health-insurer and most employer use of genetic information, but it does not cover life, disability, or long-term-care insurance. Raise this gap before testing and document insurance questions for the counselor.
